KLOW is a combination peptide protocol that includes four peptides: BPC-157 (Body Protection Compound-157), TB-500 (a fragment of Thymosin Beta-4), GHK-Cu (a copper-binding tripeptide), and KPV (an anti-inflammatory tripeptide derived from alpha-MSH)
The molecules that had an effect were then chemically manipulated to see if the effect could be increased
Nov 2022;43(4):324-338
Nomiyama, T., Kawanami, T., Irie, S., Hamaguchi, Y., Terawaki, Y., Murase, K., Tsutsumi, Y., Nagaishi, R., Tanabe, M., Morinaga, H., et al
These medications have delivered results that were, until recently, unimaginable outside of surgery: participants in clinical trials routinely lose 1520% of their body weight
You should not rely upon this content for medical advice